Fabrication of rosuvastatin-loaded polymeric nanocapsules: a promising modality for treating hepatic cancer delineated by apoptotic and cell cycle arrest assessment

References

• Abdelrahman IY, Helwa R, Elkashef H, et al. Induction of P3NS1 myeloma cell death and cell cycle arrest by simvastatin and/or γ-radiation. Asian Pac J Cancer Prev. 2015;16:7103–7110.
   PubMedGoogle Scholar
• Trojan PJJ, Bohatch-Junior MS, Otuki MF, et al. Pravastatin induces cell cycle arrest and decreased production of VEGF and bFGF in multiple myeloma cell line. Braz J Biol. 2016;76:59–65.
   PubMed Web of Science ®Google Scholar
• Janakiram NB, Mohammed A, Bryant T, et al. Potentiating NK cell activity by combination of rosuvastatin and difluoromethylornithine for effective chemopreventive efficacy against colon cancer. Sci Rep. 2016;6:37046.
   PubMed Web of Science ®Google Scholar
• Alizadeh J, Zeki AA, Mirzaei N, et al. Mevalonate cascade inhibition by simvastatin induces the intrinsic apoptosis pathway via depletion of isoprenoids in tumor cells. Sci Rep. 2017;7:44841.
   PubMed Web of Science ®Google Scholar
• Zeybek ND, Gulcelik NE, Kaymaz FF, et al. Rosuvastatin induces apoptosis in cultured human papillary thyroid cancer cells. J Endocrinol. 2011;210:105–115.
   PubMed Web of Science ®Google Scholar
• Crescencio ME, Rodríguez E, Páez A, et al. Statins inhibit the proliferation and induce cell death of human papilloma virus positive and negative cervical cancer cells. Int J Biomed Sci. 2009;5:411–420.
   PubMedGoogle Scholar
• Bjarnadottir O, Romero Q, Bendahl PO, et al. Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial. Breast Cancer Res Treat. 2013;138:499–508.
   PubMed Web of Science ®Google Scholar
• Tan M, Song X, Zhang G, et al. Statins and the risk of lung cancer: a meta-analysis. PLoS One. 2013;8:e57349.
   PubMedGoogle Scholar
• Goc A, Kochuparambil ST, Al-Husein B, et al. Simultaneous modulation of the intrinsic and extrinsic pathways by simvastatin in mediating prostate cancer cell apoptosis. BMC Cancer. 2012;12:409.
   PubMed Web of Science ®Google Scholar
• Relja B, Meder F, Wilhelm K, et al. Simvastatin inhibits cell growth and induces apoptosis and G0/G1 cell cycle arrest in hepatic cancer cells. Int J Mol Med. 2010;26:735–741.
   PubMed Web of Science ®Google Scholar
• Kulkarni NS, Ranpise NS, Mohan G. Development and evaluation of solid self nano-emulsifying formulation of rosuvastatin calcium for improved bioavailability. Trop J Pharm Res. 2015;14:575–582.
   Web of Science ®Google Scholar
• Bheemanapally K, Thimmaraju MK, Kasagoni S, et al. In vitro anti-cancer activity of rosuvastatin and ketorolac nanoformulations against DDX3. JYP. 2017;9:537–544.
   Web of Science ®Google Scholar
• Wang C, Tao W, Wang Y, et al. Rosuvastatin, identified from a Zebrafish chemical genetic screen for antiangiogenic compounds, suppresses the growth of prostate cancer. Eur Urol. 2010;58:418–426.
   PubMed Web of Science ®Google Scholar
• El Sharkawi FZ, El Shemy HA, Khaled HM. Possible anticancer activity of rosuvastatine, doxazosin, repaglinide and oxcarbazepin. Asian Pac J Cancer Prev. 2014;15:199–203.
   PubMed Web of Science ®Google Scholar
• Romana B, Batger M, Prestidge CA, et al. Expanding the therapeutic potential of statins by means of nanotechnology enabled drug delivery systems. Curr Top Med Chem. 2014;14:1182–1193.
   PubMed Web of Science ®Google Scholar
• Nasr M, Abdel-Hamid S. Lipid based nanocapsules: a multitude of biomedical applications. Curr Pharm Biotechnol. 2015;16:322–332.
   PubMed Web of Science ®Google Scholar
• Pereira MA, Mosqueira VC, Vilela JMC, et al. PLA-PEG nanocapsules radiolabeled with 99m Technetium-HMPAO: release properties and physicochemical characterization by atomic force microscopy and photon correlation spectroscopy. Eur J Pharm Sci. 2008;33:42–51.
   PubMed Web of Science ®Google Scholar
• Mora-Huertas CE, Fessi H, Elaissari A. Polymer-based nanocapsules for drug delivery. Int J Pharm. 2010;385:113–142.
   PubMed Web of Science ®Google Scholar
• Yurgel V, Collares T, Seixas F. Developments in the use of nanocapsules in oncology. Braz J Med Biol Res. 2013;46:486–501.
   PubMed Web of Science ®Google Scholar
• El-Gogary RI, Rubio N, Wang JT, et al. Polyethylene glycol conjugated polymeric nanocapsules for targeted delivery of quercetin to folate-expressing cancer cells in vitro and in vivo. ACS Nano. 2014;8:1384–1401.
   PubMed Web of Science ®Google Scholar
• Klippstein R, Wang JT, El-Gogary RI, et al. Passively targeted curcumin-loaded PEGylated PLGA nanocapsules for colon cancer therapy in vivo. Small. 2015;11:4704–4722.
   PubMed Web of Science ®Google Scholar
• Aref NM, Nasr M, Osman R. Construction and immunogenicity analysis of nanoparticulated conjugate of heat-stable enterotoxin (STa) of enterotoxigenic Escherichia coli. Int J Biol Macromol. 2018;106:730–738.
   PubMed Web of Science ®Google Scholar
• Said-Elbahr R, Nasr M, Alhnan MAA, et al. Nebulizable colloidal nanoparticles co-encapsulating a COX-2 inhibitor and a herbal compound for treatment of lung cancer. Eur J Pharm Biopharm. 2016;103:1–12.
   PubMed Web of Science ®Google Scholar
• Stecanella LA, Taveira SF, Marreto RN, et al. Development and characterization of PLGA nanocapsules of grandisin isolated from Virola surinamensis: in vitro release and cytotoxicity studies. Rev Bras Farmacogn. 2013;23:153–159.
   Google Scholar
• Maupas C, Moulari B, Beduneau A, et al. Surfactant dependent toxicity of lipid nanocapsules in HaCaT cells. Int J Pharm. 2011;411:136–141.
   PubMed Web of Science ®Google Scholar
• Bsieso EA, Nasr M, Moftah NH, et al. Could nanovesicles containing a penetration enhancer clinically improve the therapeutic outcome in skin fungal diseases? Nanomedicine (Lond). 2015;10:2017–2031.
   PubMed Web of Science ®Google Scholar
• Barakat SS, Nasr M, Ahmed RF, et al. Intranasally administered in situ gelling nanocomposite system of dimenhydrinate: preparation, characterization and pharmacodynamic applicability in chemotherapy induced emesis model. Sci Rep. 2017;7:9910.
   PubMed Web of Science ®Google Scholar
• Kaila HO, Ambasana MA, Thakkar RS, et al. A new improved RP-HPLC method for assay of rosuvastatin calcium in tablets. Indian J Pharm Sci. 2010;72:592–598.
   PubMed Web of Science ®Google Scholar
• Ashraf O, Nasr M, Nebsen M, et al. In vitro stabilization and in vivo improvement of ocular pharmacokinetics of the multi-therapeutic agent baicalin: delineating the most suitable vesicular systems. Int J Pharm. 2018;539:83–94.
   PubMed Web of Science ®Google Scholar
• Agiba AM, Nasr M, Abdel-Hamid S, et al. Enhancing the intestinal permeation of the chondroprotective nutraceuticals glucosamine sulphate and chondroitin sulphate using conventional and modified liposomes. Curr Drug Deliv. 2018;15:907–916.
   PubMed Web of Science ®Google Scholar
• Nasr M, Mansour S, Mortada ND, et al. Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. J Microencapsul. 2008;25:499–512.
   PubMed Web of Science ®Google Scholar
• Nasr M, Mansour S, Mortada ND, et al. Lipospheres as carriers for topical delivery of aceclofenac: preparation, characterization and in vivo evaluation. APPS PharmSciTech. 2008;9:154–162.
   PubMed Web of Science ®Google Scholar
• Mouez MA, Nasr M, Abdel-Mottaleb M, et al. Composite chitosan-transfersomal vesicles for improved transnasal permeation and bioavailability of verapamil. Int J Biol Macromol. 2016;93:591–599.
   PubMed Web of Science ®Google Scholar
• Nasr M. Development of an optimized hyaluronic acid-based lipidic nanoemulsion co-encapsulating two polyphenols for nose to brain delivery. Drug Deliv. 2016;23:1444–1452.
   PubMed Web of Science ®Google Scholar
• Bseiso EA, Nasr M, Sammour OA, et al. Novel nail penetration enhancer containing vesicles "nPEVs" for treatment of onychomycosis. Drug Deliv. 2016;23:2813–2819.
   PubMed Web of Science ®Google Scholar
• Nasr M, Awad GAS, Mansour S, et al. Different modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting. Eur J Pharm Biopharm. 2011;79:601–611.
   PubMed Web of Science ®Google Scholar
• Fadel M, Samy N, Nasr M, et al. Topical colloidal indocyanine green-mediated photodynamic therapy for treatment of basal cell carcinoma. Pharm Dev Technol. 2017;22:545–550.
   PubMed Web of Science ®Google Scholar
• Abdel-Lateff A, Al-Abd AM, Alahdal AM, et al. Antiproliferative effects of triterpenoidal derivatives, obtained from the marine sponge Siphonochalina sp., on human hepatic and colorectal cancer cells. Z Naturforsch C J Biosci. 2016;71:29–35.
   PubMed Web of Science ®Google Scholar
• Mosqueira VCF, Legrand P, Morgat JL, et al. Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density. Pharm Res. 2001;18:1411–1419.
   PubMed Web of Science ®Google Scholar
• Khoee S, Yaghoobian M. An investigation into the role of surfactants in controlling particle size of polymeric nanocapsules containing penicillin-G in double emulsion. Eur J Med Chem. 2009;44:2392–2399.
   PubMed Web of Science ®Google Scholar
• Katiyar SS, Muntimadugu E, Rafeeqi TA, et al. Co-delivery of rapamycin- and piperine-loaded polymeric nanoparticles for breast cancer treatment. Drug Deliv. 2015;23:1–16.
   Web of Science ®Google Scholar
• Kaur P, Garg T, Rath G, et al. Development, optimization and evaluation of surfactant-based pulmonary nanolipid carrier system of paclitaxel for the management of drug resistance lung cancer using Box–Behnken design. Drug Deliv. 2014;23:1–25.
   PubMed Web of Science ®Google Scholar
• Giannavola C, Bucolo C, Maltese A, et al. Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability. Pharm Res. 2003;20:584–590.
   PubMed Web of Science ®Google Scholar
• Lo YL. Relationships between the hydrophilic–lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines. J Control Release. 2003;90:37–48.
   PubMed Web of Science ®Google Scholar
• Goyal G, Garg T, Rath G, et al. Current nanotechnological strategies for treating glaucoma. Crit Rev Ther Drug Carrier Syst. 2014;31:365–405.
   PubMed Web of Science ®Google Scholar
• Hoosain FG, Choonara YE, Tomar LK, et al. Bypassing P-glycoprotein drug efflux mechanisms: possible applications in pharmacoresistant schizophrenia therapy. Biomed Res Int. 2015;2015:1.
   Google Scholar
• Ramzy L, Nasr M, Metwally AA, et al. Cancer nanotheranostics: a review of the role of conjugated ligands for overexpressed receptors. Eur J Pharm Sci. 2017;104:273–292.
   PubMed Web of Science ®Google Scholar
• Loch-Neckel G, Nemen D, Puhl AC, et al. Stealth and non-stealth nanocapsules containing camptothecin: in-vitro and in-vivo activity on B16-F10 melanoma. J Pharm Pharmacol. 2007;59:1359–1364.
   PubMed Web of Science ®Google Scholar
• Li Y, Pei Y, Zhang X, et al. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J Control Release. 2001;71:203–211.
   PubMed Web of Science ®Google Scholar
• Mosqueira VC, Legrand P, Pinto-Alphandary H, et al. Poly(d,l-Lactide) nanocapsules prepared by a solvent displacement process: influence of the composition on physicochemical and structural properties. J Pharm Sci. 2000;89:614–626.
   PubMed Web of Science ®Google Scholar
• Ameller T, Marsaud V, Legrand P, et al. Polyester poly(ethylene glycol) nanoparticles loaded with the pure antiestrogen RU 58668: physicochemical and opsonization properties. Pharm Res. 2003;20:1063–1070.
   PubMed Web of Science ®Google Scholar
• Klippstein R, Bansal SS, AL-Jamal KT. Doxorubicin enhances curcumin’s cytotoxicity in human prostate cancer cells in vitro by enhancing its cellular uptake. Int J Pharm. 2016;514:169–175.
   PubMedGoogle Scholar
• Chorny M, Fishbein I, Danenberg HD, et al. Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics. J Control Release. 2002;83:389–400.
   PubMed Web of Science ®Google Scholar
• Kshirsagar SJ, Bhalekar MR, Patel JN, et al. Preparation and characterization of nanocapsules for colon-targeted drug delivery system. Pharm Dev Technol. 2012;17:607–613.
   PubMed Web of Science ®Google Scholar
• Unal H, Ozturk N, Bilensoy E. Formulation development, stability and anticancer efficacy of core-shell cyclodextrin nanocapsules for oral chemotherapy with camptothecin. Beilstein J Org Chem. 2015;11:204–212.
   PubMed Web of Science ®Google Scholar
• Tatidis L, Gruber A, Vitols S. Decreased feedback regulation of low density lipoprotein receptor activity by sterols in leukemic cells from patients with acute myelogenous leukemia. J Lipid Res. 1997;38:2436–2445.
   PubMed Web of Science ®Google Scholar
• Laufs U, Liao JK. Direct vascular effects of HMG-CoA reductase inhibitors. Trends Cardiovasc Med. 2000;10:143–148.
   PubMed Web of Science ®Google Scholar
• Thurnher M, Gruenbacher G, Nussbaumer O. Regulation of mevalonate metabolism in cancer and immune cells. Biochim Biophys Acta. 2013;1831:1009–1015.
   PubMed Web of Science ®Google Scholar
• Chen CK, Law WC, Aalinkeel R, et al. Biodegradable cationic polymeric nanocapsules for overcoming multidrug resistance and enabling drug-gene co-delivery to cancer cells. Nanoscale. 2014;6:1567–1572.
   PubMed Web of Science ®Google Scholar
• Nam HK, Lee SJ, Kim MH, et al. Rosuvastatin attenuates inflammation, apoptosis and fibrosis in a rat model of cyclosporine-induced nephropathy. Am J Nephrol. 2013;37:7–15.
   PubMed Web of Science ®Google Scholar
• Martin-Renedo J, Mauriz JL, Jorquera F, et al. Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line. J Pineal Res. 2008;45:532–540.
   PubMed Web of Science ®Google Scholar
• Sampath D, Rao VA, Plunkett W. Mechanisms of apoptosis induction by nucleoside analogs. Oncogene. 2003;22:9063–9074.
   PubMed Web of Science ®Google Scholar
• Boonstra J, Post JA. Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene. 2004;337:1–13.
   PubMed Web of Science ®Google Scholar
• Chen T, Stephens PA, Middleton FK, et al. Targeting the S and G2 checkpoint to treat cancer. Drug Discov Today. 2012;17:194–202.
   PubMed Web of Science ®Google Scholar
• Zhang W, Wu J, Zhou L, et al. Fluvastatin, a lipophilic statin, induces apoptosis in human hepatocellular carcinoma cells through mitochondria-operated pathway. Indian J Exp Biol. 2010;48:1167–1174.
   PubMed Web of Science ®Google Scholar